MindMed Files Q1 2025 10-Q
Ticker: DFTX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1813814
| Field | Detail |
|---|---|
| Company | Mind Medicine (Mindmed) Inc. (DFTX) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, offering
TL;DR
MindMed's Q1 2025 10-Q is in. Check their latest financials and recent offerings.
AI Summary
Mind Medicine (MindMed) Inc. filed its 10-Q for the period ending March 31, 2025. The company's business address is One World Trade Center, Suite 8500, New York, NY 10007. Key financial events mentioned include an underwritten offering on March 7, 2024, and an at-the-market offering program on June 28, 2024.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for MindMed, crucial for understanding the company's current standing and future prospects in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a pharmaceutical company in development, MindMed faces inherent risks related to drug development, regulatory approvals, and market adoption.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for this filing.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Mind Medicine (MindMed) Inc. (company) — Filer
- 20250331 (date) — Period of Report
- 20250508 (date) — Filed as of Date
- One World Trade Center, Suite 8500, New York, NY 10007 (address) — Business and Mail Address
- 2024-03-07 (date) — Underwritten Offering Date
- 2024-06-28 (date) — At-the-Market Offering Program Date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What is Mind Medicine (MindMed) Inc.'s business address?
Mind Medicine (MindMed) Inc.'s business address is One World Trade Center, Suite 8500, New York, NY 10007.
When did MindMed have an underwritten offering?
MindMed had an underwritten offering on March 7, 2024.
When was the at-the-market offering program initiated?
The at-the-market offering program was initiated on June 28, 2024.
What is the SEC file number for MindMed?
The SEC file number for MindMed is 001-40360.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Mind Medicine (MindMed) Inc. (DFTX).